The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index; 36 of the 55 sources its claims cite were checked for support.
Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial
Open accessPublished version of a preprint
Abstract
OBJECTIVE: We tested whether the concurrence of food intake and elevated concentrations of endogenous melatonin, as occurs with late eating, results in impaired glucose control, in particular in carriers of the type 2 diabetes–associated G allele in the melatonin receptor-1B gene (MTNR1B). RESEARCH DESIGN AND METHODS: In a Spanish natural late-eating population, a randomized, crossover study was performed. Each participant (n = 845) underwent two evening 2-h 75-g oral glucose tolerance tests following an 8-h fast: an early condition scheduled 4 h prior to habitual bedtime (“early dinner timing”) and a late condition scheduled 1 h prior to habitual bedtime (“late dinner timing”), simulating an early and a late dinner timing, respectively. Differences in postprandial glucose and insulin responses between early and late dinner timing were determined using incremental area under the curve (AUC) calculated by the trapezoidal method. RESULTS: Melatonin serum levels were 3.5-fold higher in the late versus early condition, with late dinner timing resulting in 6.7% lower insulin AUC and 8.3% higher glucose AUC. The effect of late eating impairing glucose tolerance was stronger in the MTNR1B G-allele carriers than in noncarriers. Genotype differences in glucose tolerance were attributed to reductions in β-cell function (P for interaction, Pint glucose area under the curve = 0.009, Pint corrected insulin response = 0.022, and Pint disposition index = 0.018). CONCLUSIONS: Concurrently high endogenous melatonin and carbohydrate intake, as typical for late eating, impairs glucose tolerance, especially in MTNR1B G-risk allele carriers, attributable to insulin secretion defects.
Overview
CoChat Summary
TL;DR
In a randomized crossover trial of 845 Spanish natural late eaters, a glucose challenge simulating late dinner timing (1 h before habitual bedtime) impaired glucose tolerance and reduced insulin secretion compared with early dinner timing (4 h before bedtime), especially in carriers of the MTNR1B rs10830963 G risk allele. The effect appeared attributable to decreased β-cell function rather than insulin sensitivity.
Key findings
- Late versus early simulated dinner timing produced 3.5-fold higher melatonin (66.18 ± 44 vs. 22.76 ± 13.07 pg/mL), 8.3% higher glucose AUC, and 6.7% lower insulin AUC in the total population (P < 0.0001 for both AUC comparisons).
- MTNR1B rs10830963 genotype interacted with dinner timing for glucose AUC (P int = 0.009) and insulin AUC (P int = 0.035); the change in glucose AUC increased dose-dependently per G allele (β = 12.53 mg × h/dL), while the change in insulin AUC decreased per G allele (β = −9.56 mU × h/mL).
- Genotype differences were attributed to β-cell function: significant interactions were found for corrected insulin response (P int = 0.022) and disposition index (P int = 0.018), whereas insulin sensitivity index did not differ between conditions or across genotypes.
- In the late OGTT, high melatonin levels modulated insulin secretion among G carriers; a single G allele was sufficient to increase late-evening glucose when melatonin was high, but with low melatonin this difference was evident only in GG carriers, with the authors cautioning that the low-melatonin insulin AUC interaction was not significant (P int = 0.144).
Methods
- Randomized, crossover ONTIME-MT study in 845 adults of European descent, aged 38 ± 14 years, BMI 25.67 ± 4.69 kg/m², 71% female, free of diabetes and relevant medications.
- Each participant underwent two evening 2-h 75-g OGTTs after an 8-h fast: early timing 4 h before habitual bedtime (mean 19:49) and late timing 1 h before habitual bedtime (mean 22:48), with randomized order and a 1-week washout; light was bright (≥450 lux) in early and dim (0–25 lux) in late conditions.
- Glucose and insulin were measured at 0, 30, 60, 90, and 120 min; melatonin at 0 and 120 min; MTNR1B rs10830963 was genotyped. Incremental AUC was calculated by the trapezoidal method, with repeated-measures ANOVA, paired t tests, one-way/two-way ANOVA, Fisher LSD post hoc tests, and additive-model linear regression; ISI, CIR, and DI were derived and log-transformed.
Limitations
- Stated: participants were free of diabetes, so further studies in people with diabetes are needed; the study assessed only 2-h responses, and longer chronic crossover studies alternating late and early eating relative to sleep timing are needed, especially in MTNR1B G-allele carriers.
- Stated: fasting glucose was similar between conditions despite robust morning associations in prior studies, which may reflect insufficient power or the evening timing of collection; results were obtained with an OGTT and may not fully extrapolate to regular mixed meals.
- Stated: the natural late-eating population may have adapted circadian responses that limit generalizability to other eating-habit populations, although the authors report no significant interaction between habitual dinner timing and MTNR1B genotype for Δglucose or Δinsulin AUC (P = 1.000 for both). The authors also note that future studies with direct manipulation of melatonin levels are required.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
24 Valid · 3 Not valid · 8 Not checked · 56 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“These results are also in concordance with previous studies that support the”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > CONCLUSIONS
What the sources say
- Disputedcites [29] Bonnefond, 2012, Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes, Nat Genet sourceExperimental — accuracy not yet measured
The paper supports the rare-variant half: its Abstract reports that variants impairing melatonin signaling are associated with type 2 diabetes. But its discussion of the common risk allele says the observed increase in MTNR1B expression is not causal and may instead reflect impaired receptor signaling. That contradicts the claim that exaggerated signaling in common-variant carriers is detrimental. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Supportedcites [30] Mulder, 2017, Melatonin signalling and type 2 diabetes risk: too little, too much or just right?, Diabetologia source
In “MTNR1B and the genetics of type 2 diabetes,” the paper proposes that both enhanced and diminished melatonin action could adversely affect cellular function and contribute to type 2 diabetes. Its “Risk of T2D” figure identifies increased signalling with the common allele and decreased signalling with the rare allele. Page numbers are not provided in our copy. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“(in this case, enhanced melatonin signaling in MTNR1B G risk allele carriers becomes detrimental for glucose homeostasis) (29,30).”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > CONCLUSIONS
What the sources say
- Disputedcites [29] Bonnefond, 2012, Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes, Nat Genet sourceExperimental — accuracy not yet measured
The discussion passage in our copy (labeled Abstract; no page number provided) argues against the proposed mechanism: it says increased MTNR1B expression may not be causal and links impaired MT2 signaling to type 2 diabetes risk. It even suggests melatonin receptor agonists may be beneficial, contrary to the claim that enhanced signaling is detrimental. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [30] Mulder, 2017, Melatonin signalling and type 2 diabetes risk: too little, too much or just right?, Diabetologia source
The ‘MTNR1B and the genetics of type 2 diabetes’ section (page not provided) says G-allele carriers have higher MTNR1B expression and that melatonin more strongly inhibits insulin secretion when MTNR1B is overexpressed. It also reports decreased glucose tolerance and a weaker insulin response after melatonin administration to homozygous G-allele carriers. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“most studies have suggested an inhibitory effect of melatonin on insulin secretion (21,22)”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > Abstract
What the sources say
- Supportedcites [21] Peschke, 2008, Melatonin, endocrine pancreas and diabetes, J Pineal Res source
In “Recent results characterize a decrease of insulin secretion after application of melatonin” (page not supplied), the review says studies reporting inhibition are more convincing and describes reduced stimulated insulin release, with results reproduced and confirmed by others. It acknowledges contradictory early findings, but its assessment supports the citing sentence’s qualified claim. (LLM, conf=0.88)
- Partly supportedcites [22] Sharma, 2015, The role of melatonin in diabetes: therapeutic implications, Arch Endocrinol Metab sourceExperimental — accuracy not yet measured
The “Melatonin and Insulin Secretion” section says melatonin inhibits glucose-mediated insulin release and describes an inverse relationship between melatonin levels and insulin secretion. But the Introduction calls the evidence inconsistent, and the paper also describes pathways by which melatonin can increase secretion. It does not establish that *most* studies found an inhibitory effect (page numbers unavailable). (LLM, conf=0.78)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The MTNR1B risk variant rs10830963 has a strong association with fasting glucose and confers increased expression of the melatonin receptor in human pancreatic islets (11).”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > Abstract
What the sources say
- Supportedcites [11] Tuomi, 2016, Increased melatonin signaling is a risk factor for type 2 diabetes, Cell Metab source
The Introduction describes the MTNR1B variant’s association with elevated plasma glucose as a “very robust genetic association.” The paper also cites studies specifically linking MTNR1B variants to fasting glucose (References; page unavailable). (LLM, conf=0.87)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The MTNR1B risk variant rs10830963 has a strong association with fasting glucose and confers increased expression of the melatonin receptor in human pancreatic islets (11).”
- Also stated in: § CONCLUSIONS · plain
“We based our hypothesis on previous results showing that the G risk variant of MTNR1B confers increased expression of the receptor in human pancreatic islets (11)”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > Abstract
What the sources say
- Supportedcites [11] Tuomi, 2016, Increased melatonin signaling is a risk factor for type 2 diabetes, Cell Metab source
In Results and Discussion, the authors report that carriers of the rs10830963 risk allele had two- or four-fold higher MTNR1B mRNA expression in human islets. The Introduction also describes a robust association between the variant and elevated plasma glucose. The expression result concerns receptor mRNA, not a direct measurement of receptor protein. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § CONCLUSIONS · plain
45 more claims · 6 with their cited sources checked
Create a free account to see all 91 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While a few other studies (9–14) have examined the effects of melatonin administration on glycemic control, the mechanisms underlying such association remain unclear (7).”
From Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The present results align with and extend our earlier work showing that elevated melatonin—whether from exogenous administration or due to the endogenous evening rise—acutely impairs glucose tolerance, with stronger effects in MTNR1B risk allele carriers (11–14).”
From Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Average serum melatonin values were 3.5-fold higher in the LE compared with the EE timing condition (i.e., 66.18 ± 44 pg/mL LE and 22.76 ± 13.07 pg/mL EE) (Table 1).”
§ Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial > Participants
Reported 3.5 · recomputed 2.907733
Citations
Cites
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
Self-citationAdverse metabolic and cardiovascular consequences of circadian misalignment
Scheer, F. A. J. L., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808180106 · Cited by 2,351
Self-citationEntrainment of the circadian clock in the liver by feeding
Stokkan, K.-A., Yamazaki, S., Tei, H., Sakaki, Y., & Menaker, M. (2001) · Science · doi:10.1126/science.291.5503.490 · Cited by 1,800
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742
Meal timing regulates the human circadian system
Wehrens, S. M. T., Christou, S., Isherwood, C., Middleton, B., Gibbs, M. A., Archer, S. N., Skene, D. J., & Johnston, J. D. (2017) · Current Biology · doi:10.1016/j.cub.2017.04.059 · Cited by 596
Meal frequency and timing in health and disease
Mattson, M. P., Allison, D. B., Fontana, L., Harvie, M., Longo, V. D., Malaisse, W. J., Mosley, M., Notterpek, L., Ravussin, E., Scheer, F. A. J. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413965111 · Cited by 531
Self-citationMorris, C. J., Yang, J. N., Garcia, J. I., Myers, S., Bozzi, I., Wang, W., Buxton, O. M., Shea, S. A., & Scheer, F. A. J. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418955112 · Cited by 523
Self-citationHanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463
Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
Van Cauter, E., Blackman, J. D., Roland, D., Spire, J. P., Refetoff, S., & Polonsky, K. S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115396 · Cited by 448
Melatonin secretion and the incidence of type 2 diabetes
McMullan, C. J., Schernhammer, E. S., Rimm, E. B., Hu, F. B., & Forman, J. P. (2013) · JAMA · doi:10.1001/jama.2013.2710 · Cited by 369
Cited by
Genetics of circadian rhythms and sleep in human health and disease
Lane, J. M., Qian, J., Mignot, E., Redline, S., Scheer, F. A. J. L., & Saxena, R. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00519-z · Cited by 236
Self-citationMinich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176
“In one clinical trial with Spanish type 2 diabetics [130], the relationship between endogenous melatonin, dietary carbohydrate, and the effects of latenight eating were investigated.”
BackgroundBaHammam, A. S., & Pirzada, R. (2023) · Clocks & Sleep · doi:10.3390/clockssleep5030034 · Cited by 163
Circadian desynchrony and glucose metabolism
Speksnijder, E. M., Bisschop, P. H. L. T., Siegelaar, S. E., Stenvers, D. J., & Kalsbeek, A. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12956 · Cited by 107
“203 Interestingly, in the same randomized cross ‐ over trial, individuals with a MTNR1B diabetes risk variant exhibited a stronger degree of impaired glucose tolerance after late eating at night.”
BackgroundMelatonin: A potential nighttime guardian against Alzheimer’s
Zhang, Z., Xue, P., Bendlin, B. B., Zetterberg, H., Felice, F. G. D., Tan, X. W., & Benedict, C. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02691-6 · Cited by 81
Metadata
- Authors
- Garaulet, M., Lopez-Minguez, J., Dashti, H. S., Vetter, C., Hernández-Martínez, A. M., Pérez-Ayala, M., Baraza, J. C., Wang, W., Florez, J. C., Scheer, F. A. J. L., & Saxena, R.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Physiology, University of Murcia, Murcia, Spain
- Broad Institute (US)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Department of Clinical Analysis, Virgen de la Arrixaca University Hospital, Murcia, Spain
- Instituto Murciano de Investigación Biosanitaria (ES)
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- Corresponding author
- Garaulet, Marta
- Saxena, Richa
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-01-11
- Volume
- 45
- Issue
- 3
- Pages
- 512-519
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC8918262
- OpenAlex
- W4206611924
- Semantic Scholar
- dca17532a6c1a7a0e0f45925e2776dd39061c325
- Cited by
- 77
- References
- 38
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 23 · 2023: 14 · 2022: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL140574, R01HL118601, R01HL153969)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK099512, R01DK105072, K24DK110550, DK110550, R01DK102696, R01DK107859)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- late eating, MTNR1B, type 2 diabetes risk, glucose tolerance, insulin secretion, beta-cell function, endogenous melatonin, postprandial blood glucose, genetic susceptibility, disposition index
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Eating, Genotype, Glucose, Humans, Insulin, Melatonin, Risk Factors, Spain, Time Factors, Cross-Over Studies, Receptor, Melatonin, MT2, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial. https://app.cochat.ai/papers/10.2337/dc21-1314
- The paper
- Garaulet, M., Lopez-Minguez, J., Dashti, H. S., Vetter, C., Hernández-Martínez, A. M., Pérez-Ayala, M., Baraza, J. C., Wang, W., Florez, J. C., Scheer, F. A. J. L., & Saxena, R. (2022). Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial. Diabetes Care. https://doi.org/10.2337/dc21-1314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.